JP2023503513A5 - - Google Patents
Info
- Publication number
- JP2023503513A5 JP2023503513A5 JP2022531466A JP2022531466A JP2023503513A5 JP 2023503513 A5 JP2023503513 A5 JP 2023503513A5 JP 2022531466 A JP2022531466 A JP 2022531466A JP 2022531466 A JP2022531466 A JP 2022531466A JP 2023503513 A5 JP2023503513 A5 JP 2023503513A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- binder polypeptide
- polypeptide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025112713A JP7862652B2 (ja) | 2019-11-29 | 2025-07-03 | 生理学的鉄過剰の処置 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1917524.9 | 2019-11-29 | ||
| GBGB1917524.9A GB201917524D0 (en) | 2019-11-29 | 2019-11-29 | Treatment for physiological iron overload |
| GB1917882.1 | 2019-12-06 | ||
| GBGB1917882.1A GB201917882D0 (en) | 2019-12-06 | 2019-12-06 | Treatment for physiological iron overload |
| PCT/EP2020/083677 WO2021105389A1 (en) | 2019-11-29 | 2020-11-27 | Treatment for physiological iron overload |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025112713A Division JP7862652B2 (ja) | 2019-11-29 | 2025-07-03 | 生理学的鉄過剰の処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023503513A JP2023503513A (ja) | 2023-01-30 |
| JP2023503513A5 true JP2023503513A5 (enExample) | 2023-12-19 |
| JP7709436B2 JP7709436B2 (ja) | 2025-07-16 |
Family
ID=73698783
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022531466A Active JP7709436B2 (ja) | 2019-11-29 | 2020-11-27 | 生理学的鉄過剰の処置 |
| JP2025112713A Active JP7862652B2 (ja) | 2019-11-29 | 2025-07-03 | 生理学的鉄過剰の処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025112713A Active JP7862652B2 (ja) | 2019-11-29 | 2025-07-03 | 生理学的鉄過剰の処置 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12570740B2 (enExample) |
| EP (1) | EP4065607A1 (enExample) |
| JP (2) | JP7709436B2 (enExample) |
| KR (1) | KR20220107252A (enExample) |
| CN (2) | CN115380049B (enExample) |
| BR (1) | BR112022010424A2 (enExample) |
| CA (1) | CA3162880A1 (enExample) |
| CO (1) | CO2022009078A2 (enExample) |
| IL (1) | IL293314A (enExample) |
| MX (1) | MX2022006495A (enExample) |
| PH (1) | PH12022551299A1 (enExample) |
| WO (1) | WO2021105389A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021251087A1 (en) * | 2020-04-07 | 2022-12-01 | Mabwell Therapeutics Inc. | Anti-TMPRSS6 antibodies and uses thereof |
| WO2022240877A1 (en) | 2021-05-11 | 2022-11-17 | Regeneron Pharmaceuticals, Inc. | Anti-tmprss6 antibodies and uses thereof |
| CN113667600B (zh) * | 2021-07-21 | 2023-08-11 | 青岛海特生物医疗有限公司 | 用于二氧化碳培养箱功率分配的方法、装置及二氧化碳培养箱 |
| WO2026019448A1 (en) * | 2024-07-16 | 2026-01-22 | Rallybio Ipe Llc | Treatment of pathologies associated with beta-thalassemia |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6121022A (en) | 1995-04-14 | 2000-09-19 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
| EP1355919B1 (en) | 2000-12-12 | 2010-11-24 | MedImmune, LLC | Molecules with extended half-lives, compositions and uses thereof |
| WO2005023835A2 (en) * | 2003-09-09 | 2005-03-17 | Irm Llc | Modulators of transmembrane protease serine 6 |
| GB0614201D0 (en) * | 2006-07-18 | 2006-08-23 | Univ Cardiff | Matriptase-2 |
| CA2672758C (en) | 2006-12-18 | 2019-07-30 | Acceleron Pharma Inc. | Activin-actrii antagonists and uses for increasing red blood cell levels |
| JOP20080381B1 (ar) | 2007-08-23 | 2023-03-28 | Amgen Inc | بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9) |
| DK3241435T3 (da) | 2009-07-08 | 2021-08-23 | Kymab Ltd | Dyremodeller og terapeutiske molekyler |
| CN103228130B (zh) | 2010-06-17 | 2016-03-16 | 科马布有限公司 | 动物模型及治疗分子 |
| US9253965B2 (en) | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| US9139648B1 (en) | 2014-07-15 | 2015-09-22 | Kymab Limited | Precision medicine by targeting human NAV1.9 variants for treatment of pain |
| WO2016071701A1 (en) * | 2014-11-07 | 2016-05-12 | Kymab Limited | Treatment of disease using ligand binding to targets of interest |
| WO2016085852A1 (en) | 2014-11-24 | 2016-06-02 | Alnylam Pharmaceuticals, Inc. | Tmprss6 irna compositions and methods of use thereof |
| AU2016302768B2 (en) * | 2015-07-31 | 2019-08-22 | Medimmune Limited | Methods for treating hepcidin-mediated disorders |
| CN105219780B (zh) | 2015-10-30 | 2020-06-02 | 中国人民解放军第三军医大学第一附属医院 | 抗多亚基因型hcv抗体基因r3-19及其应用 |
-
2020
- 2020-11-27 EP EP20819643.6A patent/EP4065607A1/en active Pending
- 2020-11-27 CA CA3162880A patent/CA3162880A1/en active Pending
- 2020-11-27 US US17/779,504 patent/US12570740B2/en active Active
- 2020-11-27 IL IL293314A patent/IL293314A/en unknown
- 2020-11-27 BR BR112022010424A patent/BR112022010424A2/pt unknown
- 2020-11-27 CN CN202080094612.5A patent/CN115380049B/zh active Active
- 2020-11-27 WO PCT/EP2020/083677 patent/WO2021105389A1/en not_active Ceased
- 2020-11-27 CN CN202610300351.7A patent/CN122427287A/zh active Pending
- 2020-11-27 PH PH1/2022/551299A patent/PH12022551299A1/en unknown
- 2020-11-27 MX MX2022006495A patent/MX2022006495A/es unknown
- 2020-11-27 JP JP2022531466A patent/JP7709436B2/ja active Active
- 2020-11-27 KR KR1020227022002A patent/KR20220107252A/ko active Pending
-
2022
- 2022-06-29 CO CONC2022/0009078A patent/CO2022009078A2/es unknown
-
2025
- 2025-07-03 JP JP2025112713A patent/JP7862652B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515271A5 (enExample) | ||
| JP2024016177A5 (enExample) | ||
| JP2024037894A5 (enExample) | ||
| JP2023027199A5 (enExample) | ||
| JP2024102215A5 (enExample) | ||
| JP2020518598A5 (enExample) | ||
| JP2021521843A5 (enExample) | ||
| AR069062A1 (es) | Anticuerpo anti-hepcidina | |
| JP2015535828A5 (enExample) | ||
| HRP20201345T1 (hr) | Protutijela koja snažno neutraliziraju virus hepatitisa b i njihova upotreba | |
| HRP20151019T1 (hr) | PROTUTIJELA PROTIV c-MET | |
| FI3740504T3 (fi) | CD70-yhdistelmähoito | |
| JP2015514110A5 (enExample) | ||
| HRP20210393T1 (hr) | Anti-tfr antitijela i njihova uporaba u liječenju proliferativnih i upalnih poremećaja | |
| JP2018512170A5 (enExample) | ||
| EA201491571A1 (ru) | МОДИФИЦИРОВАННЫЕ БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА IgG4 С АСИММЕТРИЧНОЙ ПОСЛЕДОВАТЕЛЬНОСТЬЮ | |
| HRP20100521T1 (hr) | Monoklonska antitijela protiv čimbenika rasta hepatocita | |
| RU2010145177A (ru) | Лекарственное средство для лечения рака печени | |
| JP2023545520A5 (enExample) | ||
| RU2019104980A (ru) | Анти-icos антитела | |
| JP2020522281A5 (enExample) | ||
| JP2020522280A5 (enExample) | ||
| IL321095A (en) | Anti-c-met antibody drug conjugates | |
| NZ592436A (en) | Treatment with anti-alpha2 integrin antibodies | |
| JP2024544523A5 (enExample) |